NEXEMPA M 500 | 1000

NEXEMPA M 500 | M 1000 combines Empagliflozin with Metformin to provide effective blood sugar control for patients with type 2 diabetes, leveraging the complementary mechanisms of both drugs.

COMPOSITION:

• NEXEMPA M 500: Empagliflozin 12.5 mg + Metformin 500 mg
• NEXEMPA M 1000: Empagliflozin 12.5 mg + Metformin 1000 mg

MODE OF ACTION:

• Empagliflozin promotes urinary glucose excretion by inhibiting SGLT2 in the kidneys, lowering plasma glucose levels.
• Metformin reduces hepatic glucose production, decreases intestinal glucose absorption, and enhances insulin sensitivity in peripheral tissues.

INDICATIONS:

• Management of type 2 diabetes mellitus in adults to achieve glycemic control.
• Suitable for patients inadequately controlled on monotherapy with either Metformin or Empagliflozin.

DOSAGE:

• The usual recommended dose is 1 tablet twice daily with meals to minimize gastrointestinal side effects.
• Dose adjustments should be considered based on renal function, tolerability, and glycemic response.

STORAGE: Store at room temperature not exceeding 25ᵒC, keep in a dry place away from direct sunlight.

DISCLAIMER: This information is intended for medical professionals and registered medical practitioners only. Use of this product should be under the supervision of a registered medical practitioner with a valid prescription.